Complementary Acupuncture Treatment of Dysphagia in Stroke

NCT ID: NCT05429424

Last Updated: 2023-02-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

336 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-02-02

Study Completion Date

2025-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A Taiwanese study pointed out that stroke patients who have language barriers, dysphagia, and aspiration pneumonia are more likely to suffer from prolonged hospitalization. Improvements in dysphagia and subsequent complications in patients should be effective in reducing hospital stays and improving the quality of long-term care. In view of clinical medical needs and policy trends, this study aims to explore the efficacy of using traditional Chinese medicine to treat cerebral apoplexy sequelae in Taiwan. It is expected that through (1) exploration of real-world data analysis, combined with the advantages of Taiwan's biomedical database, data exploration will be carried out to provide big data (2) Multi-center prospective randomized clinical trials, providing clinical evidence of the highest level of evidence in empirical medicine.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors
In this study, the participants, assessor, and statistician are all blinded to the treatment assignments except for the acupuncturist and study coordinator.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Verum acupuncture group

The study uses manual acupuncture as verum intervention.

Group Type EXPERIMENTAL

Verum acupuncture group

Intervention Type OTHER

The acupuncturist disinfected the skin of the selected acupoints with alcohol, then vertically penetrated the skin with disposable stainless-steel needles (size, brand, Taiwan) to the depth predetermined for each point (between 8-25 mm, depending on the location of the acupoint) and achieved a "deqi" response, often described as a pressure, fullness, or achiness feeling around the acupoints.

Sham control group I

The study used specific made needle with a blunt tip, Streitberger device, as sham intervention.

Group Type SHAM_COMPARATOR

Sham control group I

Intervention Type OTHER

The needle does not penetrate the skin and retract in the handle while the acupuncturist needling into the skin. The participants easily believe their intervention owing to the sensation of needling into the skin that the device mimics. The needles were fixed with a plastic ring and micropore on the body of the participants without manipulation.

Sham control group II

Manual acupuncture at the points unrelated to the dysphagia is another sham intervention in this study.

Group Type SHAM_COMPARATOR

Sham control group II

Intervention Type OTHER

The acupuncturist disinfected the skin of the selected acupoints with alcohol, then vertically penetrated the skin with disposable stainless-steel needles (size, brand, Taiwan) to the depth predetermined for each point (between 8-25 mm, depending on the location of the acupoint) and achieved a "deqi" response, often described as a pressure, fullness, or achiness feeling around the acupoints.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Verum acupuncture group

The acupuncturist disinfected the skin of the selected acupoints with alcohol, then vertically penetrated the skin with disposable stainless-steel needles (size, brand, Taiwan) to the depth predetermined for each point (between 8-25 mm, depending on the location of the acupoint) and achieved a "deqi" response, often described as a pressure, fullness, or achiness feeling around the acupoints.

Intervention Type OTHER

Sham control group I

The needle does not penetrate the skin and retract in the handle while the acupuncturist needling into the skin. The participants easily believe their intervention owing to the sensation of needling into the skin that the device mimics. The needles were fixed with a plastic ring and micropore on the body of the participants without manipulation.

Intervention Type OTHER

Sham control group II

The acupuncturist disinfected the skin of the selected acupoints with alcohol, then vertically penetrated the skin with disposable stainless-steel needles (size, brand, Taiwan) to the depth predetermined for each point (between 8-25 mm, depending on the location of the acupoint) and achieved a "deqi" response, often described as a pressure, fullness, or achiness feeling around the acupoints.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* .Patients aged more than 20 years
* The diagnosis of first stroke was established within the six months
* Patients had a score ≥ 25 of Mini-Mental State Examination (MMSE)
* Patients met one or both indications as follows

1. Dysphagia confirmed under the standardized swallowing assessment
2. Nasogastric tube feeding already

Exclusion Criteria

* Previous history of swallowing disability
* Currently known coagulopathy leading to bleeding disorder.
* Previous surgery of head or neck
* Local infection at or near the acupuncture site is not suitable for acupuncture after physician examination.
* Psychological or behavior disorder
* Currently pregnant or breastfeeding women.
* Previous acupuncture treatment for any indication within 30 days of enrollment.
* Severe chronic or uncontrollable complications interference the processing of the trial
Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

China Medical University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

China Medicine University China Medicine University

Role: STUDY_CHAIR

China Medicine University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

China Medical University Hospital

Taichung, , Taiwan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hung-Rong Yen

Role: CONTACT

04-22053366 ext. 3313

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hung-Rong Yen

Role: primary

04-22053366 ext. 3501

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CMUH111-REC1-065

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.